Syon Schlecht,
CEO and Executive Director 

At Syon Biosciences, we believe the next revolution in human health will be powered by precision: small molecule therapeutics designed to outpace the toughest biological challenges.

Founder and CEO Syon Schlecht brings a unique cross-disciplinary approach to this mission. With a background in biochemistry, molecular biology, and engineering from Georgia Tech, Syon has built his career at the intersection of science, medicine, and innovation. His research has focused on unlocking microbial ecosystems and natural molecular pathways to develop new strategies against disease. 

Syon Biosciences is committed to a new model for biotech: agile, discovery-driven, and impact-focused. Under Syon’s leadership, we aim to transform natural molecules into powerful therapeutics, forging a pipeline of next-generation small molecule drugs designed to meet the world’s most pressing needs.